Navigation Links
Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014
Date:5/26/2009

Market Scope has announced the publication of the recently updated 2009 editions of two of its three comprehensive reports on the retinal products industry. According to Market Scope, this is a very exciting time in the retinal products market. New anti-VEGF therapies are successfully treating vision-threatening retinal diseases that, in the recent past, had been largely untreatable. Investigational devices are promising to restore some sight to those who have lost much of their vision. And new diagnostic technologies are allowing the intricate layers of the retina to be visualized with greater clarity and detail than ever before.

St. Louis, MO (PRWEB) May 22, 2009- In the midst of significant advances, demand for retinal treatments is soaring, driven by rapid growth in elderly populations, increases in diabetes, greater access to medical care in emerging economies, and rapidly evolving quality-of-life expectations among aging populations. "The new tools and technologies have mixed with burgeoning demand to create significant opportunity in the rapidly transforming market for retinal pharmaceuticals and devices," according to David Harmon, Market Scope's president.

The retinal pharmaceutical market is no longer a backwater with few products; it has rapidly evolved into one of the largest segments in the ophthalmic pharmaceutical industry. Anti-VEGF therapies have significantly changed the prognosis for those suffering from age-related macular degeneration (AMD). The benefits from these new drugs are dramatic, but much of the commercial oppor
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
6. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
9. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
10. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... "fountain of youth" drug that can delay the effects of ... study suggests. Seniors received a significant boost to their ... signaling pathway linked to aging and immune function, researchers with ... medication, a version of the drug rapamycin, improved the seniors, ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... Association of Canada states that learning disabilities diagnosed ... on people. Depression, anxiety, suicidal thoughts and unemployment ... with such disabilities. ,Philippa Slater, B.C. ... finding and says that many such people resort ...
... Danish study shows that if you happen to posses a ... ,The gene in question is a specific ... associated with increased iron accumulation, which affects how the body ... Without treatment, the condition causes liver enlargement ...
... of tiny babies born in UK is increasing. The researchers ... weighing less than 2.5kg in 2006. In 1989, it was ... has also urged the government to provide more financial support ... care for all newborns in intensive care. According to the ...
... with cacao liquor proanthocyanidins (CLPr) reduced blood glucose ... human diabetics// significant benefits, says a new study ... can dose-dependently prevent the development of hyperglycaemia in ... in the journal Nutrition. "The dietary intake of ...
... joint HIV surveillance and prevention efforts, which they began in ... governments reported record numbers of HIV cases in 2006, China ... Hong Kong Department of Health reported 373 new HIV cases ... in 2005. Guangdong reported 4,823 new HIV cases from January ...
... with terms like ‘grumpy old man’, ‘old fogies’ and other such, ... it’s older people who are more optimistic about life. ... older, and it is the young who tend to have a ... of a survey of 150 persons, the subjects of varied ages ...
Cached Medicine News:Health News:Gene Mutation Linked With Risks of Stroke 2Health News:Cocoa Polyphenols may Offer Diabetes Benefits - Study 2Health News:Hong Kong, Guangdong Province To Increase Joint HIV/AIDS Surveillance 2
(Date:12/24/2014)... DUBLIN , Dec. 24, 2014  Actavis ... that the Company has received a complete response ... (FDA) for its New Drug Application (NDA) for ... for the treatment of hypertension.   Photo ... we are disappointed in the receipt of a ...
(Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
... MASPETH N.Y., May 1, 2012 /PRNewswire-iReach/ ... global expedited transportation, logistics, and warehouse fulfillment services, ... Tom Brennan as Vice President Strategic Accounts & ... be responsible for implementing and accelerating critical strategic ...
... MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that ... 2012: Deutsche Bank 37th Annual Healthcare Conference Tuesday, May ... America Merrill Lynch 2012 Healthcare Conference Tuesday, May 15, at 3:40 ... each event will be available on the Investor Relations section of ...
Cached Medicine Technology:Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences 2Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences 3
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Medicine Products: